Utility of Plasma Beta-Hydroxybutyrate to Define Resolution of Diabetic Ketoacidosis. Tremblay ES, Millington K, Wu Y, Wypij D, et al. Pediatr Diabetes 2022 Oct 20. doi: 10.1111/pedi.13437.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tremblay ES, Millington K, Wu Y, Wypij D, et al. Utility of Plasma Beta-Hydroxybutyrate to Define Resolution of Diabetic Ketoacidosis. Pediatr Diabetes 2022 Oct 20. doi: 10.1111/pedi.13437.
PMID: 36268546